£49.34

CRC Press Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Chapman & Hall/CRC Biostatistics Series)

Price data last checked 94 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£49 today · previous high £49 · all-time low £44

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 637 days • 637 data points (No recent data available)

Historical
Generating forecast...
£49.34 £43.57 £44.83 £46.09 £47.35 £48.61 £49.87 09 June 2024 15 November 2024 23 April 2025 29 September 2025 07 March 2026

Price Distribution

Price distribution over 637 days • 4 price levels

Days at Price
Current Price
272 days 208 days 120 days 37 days · current 0 68 136 204 272 £44 £46 £47 £49 Days at Price

Price Analysis

Most common price: £44 (272 days, 42.7%)

Price range: £44 - £49

Price levels: 4 different prices over 637 days

Description

The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation. About the Author Harry Yang, Ph.D., is senior director and head of the Non-Clinical Biostatistics Group at MedImmune, the global biologics arm of AstraZeneca headquartered in Gaithersburg, Maryland.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
18 December 2020
Listed Since
14 October 2020

Barcode

No barcode data available

Similar Products You Might Like

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Chapman & Hall/CRC Biostatistics Series)
98% match

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£86.76 27 Feb 2026
Quality by Design for Biopharmaceuticals: Principles and Case Studies (Wiley Series in Biotechnology and Bioengineering)
96% match

Quality by Design for Biopharmaceuticals: Principles and Case Studies (Wiley Series in Biotechnology and Bioengineering)

Wiley

£109.68 18 Feb 2026
Statistical Design and Analysis in Pharmaceutical Science: Validation, Process Controls, and Stability: 143 (Statistics: Textbooks and Monographs)
96% match

Statistical Design and Analysis in Pharmaceutical Science: Validation, Process Controls, and Stability: 143 (Statistics: Textbooks and Monographs)

CRC Press

£63.94 08 Mar 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)
96% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.33 20 Feb 2026
Pharmaceutical Quality by Design Using JMP®: Solving Product Development and Manufacturing Problems
96% match

Pharmaceutical Quality by Design Using JMP®: Solving Product Development and Manufacturing Problems

SAS Institute

£69.07 05 Mar 2026
Pharmaceutical Quality by Design: A Practical Approach (Advances in Pharmaceutical Technology)
96% match

Pharmaceutical Quality by Design: A Practical Approach (Advances in Pharmaceutical Technology)

Wiley

£61.38 13 Jan 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
96% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 08 Mar 2026
Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)
96% match

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Springer

£118.95 24 Feb 2026
Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)
96% match

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Springer

£124.39 22 Jan 2026
Statistical Development of Quality in Medicine: 63 (Statistics in Practice)
96% match

Statistical Development of Quality in Medicine: 63 (Statistics in Practice)

Wiley

£76.95 26 Feb 2026
Statistical Methods in Biomarker and Early Clinical Development
95% match

Statistical Methods in Biomarker and Early Clinical Development

£104.17 12 Jan 2026
Pharmaceutical Quality by Design: Principles and Applications
95% match

Pharmaceutical Quality by Design: Principles and Applications

Academic Press

£132.95 14 Feb 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
95% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£42.31 28 Feb 2026
Quality by Design for Biopharmaceutical Drug Product Development: 18 (AAPS Advances in the Pharmaceutical Sciences Series, 18)
95% match

Quality by Design for Biopharmaceutical Drug Product Development: 18 (AAPS Advances in the Pharmaceutical Sciences Series, 18)

Springer

£141.44 07 Mar 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
95% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£110.95 25 Feb 2026
Statistical Methods in Biomarker and Early Clinical Development
95% match

Statistical Methods in Biomarker and Early Clinical Development

Springer

£105.00 09 Mar 2026
Statistical Thinking for Non-Statisticians in Drug Regulation
95% match

Statistical Thinking for Non-Statisticians in Drug Regulation

Wiley-Blackwell

£60.99 25 Jan 2026
Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (Statistics for Biology and Health)
95% match

Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (Statistics for Biology and Health)

Springer

£63.24 28 Feb 2026
Comprehensive Quality by Design for Pharmaceutical Product Development and Manufacture
95% match

Comprehensive Quality by Design for Pharmaceutical Product Development and Manufacture

Wiley

£109.60 19 Apr 2026
Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)
95% match

Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)

SAS Institute

£74.12 18 Apr 2026
Introduction to Quality by Design in Pharmaceutical Manufacturing and Analytical Development: 10 (AAPS Introductions in the Pharmaceutical Sciences, 10)
95% match

Introduction to Quality by Design in Pharmaceutical Manufacturing and Analytical Development: 10 (AAPS Introductions in the Pharmaceutical Sciences, 10)

Springer

£94.32 25 Jan 2026
Introduction to Quality by Design in Pharmaceutical Manufacturing and Analytical Development: 10 (AAPS Introductions in the Pharmaceutical Sciences, 10)
95% match

Introduction to Quality by Design in Pharmaceutical Manufacturing and Analytical Development: 10 (AAPS Introductions in the Pharmaceutical Sciences, 10)

Springer

£103.28 24 Jan 2026
Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches (Chapman & Hall/CRC Biostatistics Series)
95% match

Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£93.00 25 Jan 2026
Statistical Methods in Healthcare
95% match

Statistical Methods in Healthcare

Wiley

£86.48 20 Feb 2026